Vaccine
(rabbit numbers) |
Papilloma sites |
Protected sites |
Protection rate |
CRPVE1/161-169
(N=8) |
24 |
32 |
24/32
(75%) a |
CRPVE1/303-311
(N=5) |
20 |
20 |
20/20
(100%) a |
CRPVE1/245-253
(N=4) |
4 |
12 |
12/16
(75%) a |
CRPVE1/42-50
(N=4) |
4 |
12 |
12/16
(75%) a |
CRPVE1/149-157
(N=3) |
0 |
12 |
12/12
(100%) b |
HPV16E7/82-90
(N=4) |
14 |
2 |
2/16
(12.5%) |
aP=0.02 and bP=0.01 vs. HPV16E7/82-90 group, Fisher’s exact test |